Sofinnova Partners is a leading European venture capital firm specializing in life sciences, healthcare, and sustainability. Founded in 1972 and headquartered in Paris, it acts as a hands-on company builder across the entire value chain of life sciences investments, from incubation through later-stage growth.
53% of their portfolio is in Biotech & Life Sciences. Deal activity increased 31% year-over-year (17 deals in the last 12 months). Average disclosed round size is $69.2M (across 154 rounds with reported amounts).
Portfolio
161
Fund Size
$750M
Top Stage
Series A
Last 12 Mo
15
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
223 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Mironid | Series B | $46M | Aug 2026 |
 City Therapeutics | Series B | $99.5M | Jun 2026 |
| PP2 Science, Inc. | Unknown | $23M | May 2026 |
 CellCentric | Series D | $220M | May 2026 |
 Verley | Series A | — | Feb 2026 |
 Neurent Medical | Series C | $74M | Feb 2026 |
 Tenpoint Therapeutics | Series B | $85M | Jan 2026 |
 BrightHeart | Series A | — | Jan 2026 |
| CClaris Bio | Series B | — | Jan 2026 |
 Artios Pharma | Series D | $115M | Nov 2025 |
| AArtios | Series D | $115M | Nov 2025 |
| HHemab | Series C | $157M | Oct 2025 |
 Mission Therapeutics | Unknown | $13.3M | Oct 2025 |
| NNanoPhoria Bioscience | Series A | — | Oct 2025 |
| SSafeHeal | Series C | $10M | Sep 2025 |
 Galvanize Therapeutics | Series C | $100M | Sep 2025 |
 Elevara Medicines | Series A | $70M | Sep 2025 |
 ArtBio | Series B | $132M | Jul 2025 |
 One Biosciences | Series A | — | Jul 2025 |
 Enyo Pharma | Series C | — | Jun 2025 |
 GlycoEra | Series B | $130M | May 2025 |
 Atsena Therapeutics | Series C | $150M | Apr 2025 |
 Latent Labs | Series A | $40M | Feb 2025 |
 Digital MedicineLatent Labs | Series A | $50M | Feb 2025 |
 Bioptimus | Series A | $41M | Jan 2025 |
Page 1 of 9
Top Co-Investors
Pfizer Ventures23 shared
Novo Capital17 shared
Forbion16 shared
The Invus Group, LLC15 shared
Andera Partners15 shared
RA Capital Management14 shared
M Ventures14 shared
Alexandria Venture Investments12 shared
Surveyor Capital12 shared
Cormorant Asset Management12 shared
T. Rowe Price12 shared
Arix Bioscience12 shared
SV Health Investors12 shared
Novo Holdings A/S11 shared
Omega Funds11 shared
Bpifrance11 shared
OrbiMed11 shared
Venrock11 shared
Rock Springs Capital10 shared
venBio9 shared
Last updated: 7 September 2026